AS ameliorated learning and memory deficits in Aβ1-42-induced mice. Mice were injected with Aβ1-42 (2 μg/μL, 5 μL, i.c.v.) followed by AS treatment (40 mg/kg, i.g.). (A) Schematic representation of the experimental design. (B) Average swimming speed for each experimental group. (C) Distance traversed by different groups during the test. (D) Latency to locate the target platform during the final exploration trial. (E) Time spent in the target quadrant during the last exploration trial (F) Swimming paths of mice to target the hidden platform during the final exploration trial. Data are presented as mean ± SEM (n ≥ 3). * p < 0.05, model vs. control group; #
p < 0.05, AS vs. model group.